With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer
Oncology
0 drugs in development·0 companies·1 clinical trial
Deep-dive into With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis